Most Popular Stories
Featured Jobs
-
Pain Medicine Physician Job in Indiana
StaffPointe, LLC - near Indianapolis, IN -
Medication Management Job in Tennessee
StaffPointe, LLC - Knoxville, TN -
Family Practice Job in Oregon
StaffPointe, LLC - west, OR -
Nurse Practitioner Job in California
StaffPointe, LLC - near Los Angeles, CA -
Family Nurse Practitioner
Makro Health - Grundy
Events
- Harvard Business School 7th Healthcare Conference
January 30, 2010
Paid Research Reports
- Pricing and Reimbursement in Key Asia Pacific Markets
- Delivery Mechanisms for Large Molecule Drugs: Successes and failures of leading technologies and key drivers for market success
- The Cardiovascular Market Outlook to 2013: Competitive landscape, global market analysis and pipeline analysis
- Intellectual Property and Outsourcing in China: Minimizing risk whilst maximizing return on investment
- Health Care Equipment & Supplies: Global Industry Guide
- 2009 Trends to Watch: Healthcare Technology
FEATURES >> YouTube | Top acute-care hospitals | Women in Health IT | Top BlackBerry Apps | Commentary
TOPICS >> Stimulus | Health Reform | CMS News | Finance | EMRs | Mobile Healthcare | Hospital Leadership Blog
Free Newsletter
FierceHealthcare is the leading source of healthcare management news for healthcare industry executives. Join 50,000+ healthcare industry insiders who get FierceHealthcare via daily email. Sign up today!
Popular Topics
- Medicare
- health plans
- Centers for Medicare and Medicaid Services (CMS)
- Insurance
- Electronic Medical Records (EMRs)
- Food and Drug Administration (FDA)
- Department of Health and Human Services (HHS)
- Medicaid
- American Medical Association (AMA)
- healthcare system
- health reform
- prescription drugs
- pharmaceutical companies
Vioxx lawsuits continue to multiply
Following the $253 million jury award in Ernst v. Merck, thousands of people have filed new lawsuits against the drug maker over its painkiller Vioxx. Court documents show that 1,500 new suits have been filed against the company in the eight weeks since the case ended. That brings the total number of suits filed against the company over its maligned Cox-2 inhibitor to 6,500. The award in the Texas case was capped under state laws limiting punitive damages, reducing it dramatically, but that hasn't stopped the verdict from inspiring the follow-on suits. The attorney representing the plaintiff in the Atlantic City Vioxx trial said he expects as many as 10,000 to 15,000 additional suits to be filed in New Jersey by the end of the year.
- see this article from the Boston Globe
Related Stories
- Merck's position seen as tenuous
- FL, IA legislatures pass CON reforms
- GAO report details problems at FDA
- SPOTLIGHT: Scientists stand by Vioxx research
- Merck scores victory in second Vioxx trial
- Lanier 'Dream Team' to file thousands of new Vioxx claims
- SPOTLIGHT: A little pain relief for Merck
- Judge rebukes Merck attorney in Vioxx case
- Second Vioxx trial opens in NJ
- Jury awards Ernst $253.5M in Vioxx suit
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site Map | List in Marketplace | Supplier MarketplaceTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2009 FierceMarkets, Inc. All rights reserved. |
![]() |





